These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 31610377)

  • 1. Structure-activity relationship study of NPP1 inhibitors based on uracil-N1-(methoxy)ethyl-β-phosphate scaffold.
    Nassir M; Pelletier J; Arad U; Arguin G; Khazanov N; Gendron FP; Sévigny J; Senderowitz H; Fischer B
    Eur J Med Chem; 2019 Dec; 184():111754. PubMed ID: 31610377
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adenine-(methoxy)-ethoxy-P
    Nassir M; Mirza S; Arad U; Lee S; Rafehi M; Yaw Attah I; Renn C; Zimmermann H; Pelletier J; Sévigny J; Müller CE; Fischer B
    Org Biomol Chem; 2019 Nov; 17(46):9913-9923. PubMed ID: 31720670
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of adenine-N9-(methoxy)ethyl-β-bisphosphonate as NPP1 inhibitor attenuates NPPase activity in human osteoarthritic chondrocytes.
    Nassir M; Arad U; Lee SY; Journo S; Mirza S; Renn C; Zimmermann H; Pelletier J; Sévigny J; Müller CE; Fischer B
    Purinergic Signal; 2019 Jun; 15(2):247-263. PubMed ID: 31025169
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Highly Selective and Potent Ectonucleotide Pyrophosphatase-1 (NPP1) Inhibitors Based on Uridine 5'-P
    Zelikman V; Pelletier J; Simhaev L; Sela A; Gendron FP; Arguin G; Senderowitz H; Sévigny J; Fischer B
    J Med Chem; 2018 May; 61(9):3939-3951. PubMed ID: 29681152
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Highly potent and selective ectonucleotide pyrophosphatase/phosphodiesterase I inhibitors based on an adenosine 5'-(α or γ)-thio-(α,β- or β,γ)-methylenetriphosphate scaffold.
    Nadel Y; Lecka J; Gilad Y; Ben-David G; Förster D; Reiser G; Kenigsberg S; Camden J; Weisman GA; Senderowitz H; Sévigny J; Fischer B
    J Med Chem; 2014 Jun; 57(11):4677-91. PubMed ID: 24846781
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thiazolo[3,2-a]benzimidazol-3(2H)-one derivatives: Structure-activity relationships of selective nucleotide pyrophosphatase/phosphodiesterase1 (NPP1) inhibitors.
    Lee SY; Perotti A; De Jonghe S; Herdewijn P; Hanck T; Müller CE
    Bioorg Med Chem; 2016 Jul; 24(14):3157-65. PubMed ID: 27265686
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nonhydrolyzable ATP analogues as selective inhibitors of human NPP1: a combined computational/experimental study.
    Lecka J; Ben-David G; Simhaev L; Eliahu S; Oscar J; Luyindula P; Pelletier J; Fischer B; Senderowitz H; Sévigny J
    J Med Chem; 2013 Nov; 56(21):8308-20. PubMed ID: 24083941
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis of biphenyl oxazole derivatives via Suzuki coupling and biological evaluations as nucleotide pyrophosphatase/phosphodiesterase-1 and -3 inhibitors.
    Ahmad H; Ullah S; Rahman F; Saeed A; Pelletier J; Sévigny J; Hassan A; Iqbal J
    Eur J Med Chem; 2020 Dec; 208():112759. PubMed ID: 32883636
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and biological evaluation of novel quinazoline-4-piperidinesulfamide derivatives as inhibitors of NPP1.
    Forcellini E; Boutin S; Lefebvre CA; Shayhidin EE; Boulanger MC; Rhéaume G; Barbeau X; Lagüe P; Mathieu P; Paquin JF
    Eur J Med Chem; 2018 Mar; 147():130-149. PubMed ID: 29427906
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis, biological evaluation, and docking studies of novel pyrrolo[2,3-b]pyridine derivatives as both ectonucleotide pyrophosphatase/phosphodiesterase inhibitors and antiproliferative agents.
    Ullah S; El-Gamal MI; El-Gamal R; Pelletier J; Sévigny J; Shehata MK; Anbar HS; Iqbal J
    Eur J Med Chem; 2021 May; 217():113339. PubMed ID: 33744686
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Large-volume sample stacking with polarity switching for monitoring of nucleotide pyrophosphatase/phosphodiesterase 1 (NPP1) reactions by capillary electrophoresis.
    Lee SY; Müller CE
    Electrophoresis; 2014 Mar; 35(6):855-63. PubMed ID: 24431193
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of sulfonate and sulfamate derivatives possessing benzofuran or benzothiophene nucleus as inhibitors of nucleotide pyrophosphatases/phosphodiesterases and anticancer agents.
    Anbar HS; El-Gamal R; Ullah S; Zaraei SO; Al-Rashida M; Zaib S; Pelletier J; Sévigny J; Iqbal J; El-Gamal MI
    Bioorg Chem; 2020 Nov; 104():104305. PubMed ID: 33017718
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quinazoline-4-piperidine sulfamides are specific inhibitors of human NPP1 and prevent pathological mineralization of valve interstitial cells.
    Shayhidin EE; Forcellini E; Boulanger MC; Mahmut A; Dautrey S; Barbeau X; Lagüe P; Sévigny J; Paquin JF; Mathieu P
    Br J Pharmacol; 2015 Aug; 172(16):4189-99. PubMed ID: 26031197
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis, in vitro, and in silico studies of morpholine-based thiosemicarbazones as ectonucleotide pyrophosphatase/phosphodiesterase-1 and -3 inhibitors.
    Tasleem M; Pelletier J; Sévigny J; Hussain Z; Khan A; Al-Harrasi A; El-Kott AF; Taslimi P; Negm S; Shafiq Z; Iqbal J
    Int J Biol Macromol; 2024 May; 266(Pt 2):131068. PubMed ID: 38531526
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Imidazopyridine- and purine-thioacetamide derivatives: potent inhibitors of nucleotide pyrophosphatase/phosphodiesterase 1 (NPP1).
    Chang L; Lee SY; Leonczak P; Rozenski J; De Jonghe S; Hanck T; Müller CE; Herdewijn P
    J Med Chem; 2014 Dec; 57(23):10080-100. PubMed ID: 25372276
    [TBL] [Abstract][Full Text] [Related]  

  • 16. alpha- and beta-substituted phosphonate analogs of LPA as autotaxin inhibitors.
    Cui P; McCalmont WF; Tomsig JL; Lynch KR; Macdonald TL
    Bioorg Med Chem; 2008 Mar; 16(5):2212-25. PubMed ID: 18082408
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis, biological evaluation, and docking studies of new raloxifene sulfonate or sulfamate derivatives as inhibitors of nucleotide pyrophosphatase/phosphodiesterase.
    El-Gamal MI; Ullah S; Zaraei SO; Jalil S; Zaib S; Zaher DM; Omar HA; Anbar HS; Pelletier J; Sévigny J; Iqbal J
    Eur J Med Chem; 2019 Nov; 181():111560. PubMed ID: 31382118
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anticancer activity of FTY720: phosphorylated FTY720 inhibits autotaxin, a metastasis-enhancing and angiogenic lysophospholipase D.
    van Meeteren LA; Brinkmann V; Saulnier-Blache JS; Lynch KR; Moolenaar WH
    Cancer Lett; 2008 Aug; 266(2):203-8. PubMed ID: 18378389
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Probing the high potency of pyrazolyl pyrimidinetriones and thioxopyrimidinediones as selective and efficient non-nucleotide inhibitors of recombinant human ectonucleotidases.
    Andleeb H; Hameed S; Ejaz SA; Khan I; Zaib S; Lecka J; Sévigny J; Iqbal J
    Bioorg Chem; 2019 Jul; 88():102893. PubMed ID: 30986550
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Specificity of the ecto-ATPase inhibitor ARL 67156 on human and mouse ectonucleotidases.
    Lévesque SA; Lavoie EG; Lecka J; Bigonnesse F; Sévigny J
    Br J Pharmacol; 2007 Sep; 152(1):141-50. PubMed ID: 17603550
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.